A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
- DOI
- 10.1186/s13046-019-1121-3
- Published
- 2019-03-12
- Container
- Journal of Experimental & Clinical Cancer Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-019-1121-3,
title = {A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors},
author = {Hiroshi Fukamachi and Seon-Kyu Kim and Jiwon Koh and Hye Seung Lee and Yasushi Sasaki and Kentaro Yamashita and Taketo Nishikawaji and Shu Shimada and Yoshimitsu Akiyama and Sun-ju Byeon and Dong-Hyuck Bae and Keisuke Okuno and Masatoshi Nakagawa and Toshiro Tanioka and Mikito Inokuchi and Hiroshi Kawachi and Kiichiro Tsuchiya and Kazuyuki Kojima and Takashi Tokino and Yoshinobu Eishi and Yong Sung Kim and Woo Ho Kim and Yasuhito Yuasa and Shinji Tanaka},
year = {2019},
journal = {Journal of Experimental \& Clinical Cancer Research},
doi = {10.1186/s13046-019-1121-3},
url = {https://doi.org/10.1186/s13046-019-1121-3}
}RIS
TY - JOUR TI - A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors AU - Hiroshi Fukamachi AU - Seon-Kyu Kim AU - Jiwon Koh AU - Hye Seung Lee AU - Yasushi Sasaki AU - Kentaro Yamashita AU - Taketo Nishikawaji AU - Shu Shimada AU - Yoshimitsu Akiyama AU - Sun-ju Byeon AU - Dong-Hyuck Bae AU - Keisuke Okuno AU - Masatoshi Nakagawa AU - Toshiro Tanioka AU - Mikito Inokuchi AU - Hiroshi Kawachi AU - Kiichiro Tsuchiya AU - Kazuyuki Kojima AU - Takashi Tokino AU - Yoshinobu Eishi AU - Yong Sung Kim AU - Woo Ho Kim AU - Yasuhito Yuasa AU - Shinji Tanaka PY - 2019 JO - Journal of Experimental & Clinical Cancer Research DO - 10.1186/s13046-019-1121-3 UR - https://doi.org/10.1186/s13046-019-1121-3 ER -
APA
Fukamachi, H., Kim, S., Koh, J., Lee, H. S., Sasaki, Y., Yamashita, K., Nishikawaji, T., Shimada, S., Akiyama, Y., Byeon, S., Bae, D., Okuno, K., Nakagawa, M., Tanioka, T., Inokuchi, M., Kawachi, H., Tsuchiya, K., Kojima, K., Tokino, T., Eishi, Y., Kim, Y. S., Kim, W. H., Yuasa, Y., & Tanaka, S. (2019). A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-019-1121-3
Source records
- crossref · retrieved 2026-09-26T12:27:06.877Z